Michael E. Carney

39.2k citations

41 papers · 1.6k indexed · h-index 18

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments

Papers in ⓘ

Reproductive Medicine 24
- Ovarian cancer diagnosis and treatment 23
- Endometriosis Research and Treatment 3
Obstetrics and Gynecology 16
- Endometrial and Cervical Cancer Treatments 14

Co-authors: Lynda Bergsma (1 shared paper)Andrew Berchuck (6 shared papers)Johnathan M. Lancaster (5 shared papers)Charles L. Wiggins (2 shared papers)Alexander Tsodikov (2 shared papers)Clyde D. Ford (2 shared papers)Craig C. Earle (1 shared paper)Robert E. Bristow (1 shared paper)
Journals: Gynecologic Oncology (10 papers)American Journal of Obstetrics and Gynecology (2 papers)Cancer Control (2 papers)Journal of Clinical Oncology (2 papers)International Journal of Gynecological Cancer (1 paper)
Partner nations: United States Japan Ireland

In The Last Decade

Michael E. Carney

39 papers receiving 1.6k citations

Peers

Countries citing papers authored by Michael E. Carney

Since Specialization

Citations

This map shows the geographic impact of Michael E. Carney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Carney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Carney more than expected).

Fields of papers citing papers by Michael E. Carney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Carney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Carney. The network helps show where Michael E. Carney may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Carney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Carney Line = papers co-authored together Michael E. Carney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients JNCI Journal of the National Cancer Institute ·Craig C. Earle, Deborah Schrag, Bridget A. Neville, K. Robin Yabroff, Marie Topor, Angela Fahey, Edward L. Trimble, Diane C. Bodurka, Robert E. Bristow, Michael E. Carney, Joan L. Warren	2006	326
2	Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209) Journal of Clinical Oncology ·David S. Miller, Virginia L. Filiaci, Robert S. Mannel, David E. Cohn, Takashi Matsumoto, Krishnansu S. Tewari, Paul DiSilvestro, Michael L. Pearl, Peter A. Argenta, Matthew A. Powell, Susan Zweizig, David Warshal, Parviz Hanjani, Michael E. Carney, Helen Huang, David Cella, Richard J. Zaino, Gini F. Fleming	2020	200
3	A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not? Gynecologic Oncology ·Michael E. Carney, Johnathan M. Lancaster, Clyde D. Ford, Alexander Tsodikov, Charles L. Wiggins	2002	167
4	Effectiveness of health-promoting media literacy education: a systematic review Health Education Research ·Lynda Bergsma, Michael E. Carney	2008	153
5	Human ovarian cancer of the surface epithelium Biochemical Pharmacology ·Andrew Berchuck, Michael E. Carney	1997	72
6	Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer Gynecologic Oncology ·Abigail W. Bushley, Robert E. Ferrell, Katharine McDuffie, Keith Y. Terada, Michael E. Carney, Pamela J. Thompson, Lynne R. Wilkens, Ko-Hui Tung, Roberta B. Ness, Marc T. Goodman	2004	66
7	Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer Gynecologic Oncology ·Laura J. Havrilesky, Angeles A. Alvarez, Robyn Sayer, Johnathan M. Lancaster, John T. Soper, Andrew Berchuck, Daniel L. Clarke‐Pearson, Gustavo C. Rodriguez, Michael E. Carney	2002	64
8	Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer JAMA Oncology ·Debra L. Richardson, Michael W. Sill, Robert L. Coleman, Anil K. Sood, Michael L. Pearl, Siobhan M. Kehoe, Michael E. Carney, Parviz Hanjani, Linda Van Le, Xun Zhou, Angeles Alvarez Secord, Heidi J. Gray, Lisa M. Landrum, Heather A. Lankes, Wei Hu, Carol Aghajanian	2017	58
9	Current Understanding of Risk Factors for Ovarian Cancer Current Treatment Options in Oncology ·Thanasak Sueblinvong, Michael E. Carney	2009	56
10	Microcystic adnexal carcinoma arising in the setting of previous radiation therapy Journal of Cutaneous Pathology ·C. A. Antley, Michael E. Carney, Bruce R. Smoller	1999	48
11	Stage at diagnosis of ovarian cancer in the United States, 1992-1997 Cancer ·Marc T. Goodman, Catherine N. Correa, Ko‐Hui Tung, Steven Roffers, Xiao Wu, John L. Young, Lynne R. Wilkens, Michael E. Carney, Holly L. Howe	2003	46
12	A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer. Journal of Clinical Oncology ·Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher, William P. Tew, Noelle Cloven, Carolyn Y. Muller, David Bender, Richard G. Moore, David P. Michelin, Steven Waggoner, Melissa A. Geller, Keiichi Fujiwara, Stacy D. D’Andre, Michael E. Carney, Angeles Alvarez Secord, Katherine Moxley, Michael A. Bookman	2020	45
13	Combined Oral Contraceptive Use and Epithelial Ovarian Cancer Risk Epidemiology ·Galina Lurie, Lynne R. Wilkens, Pamela J. Thompson, Katharine McDuffie, Michael E. Carney, Keith Y. Terada, Marc T. Goodman	2008	37
14	Prediagnostic symptoms of ovarian carcinoma: A case-control study Gynecologic Oncology ·Galina Lurie, Pamela J. Thompson, Katharine McDuffie, Michael E. Carney, Marc T. Goodman	2009	29
15	Ovarian Cancer Hormonal and Environmental Risk Effect Obstetrics and Gynecology Clinics of North America ·Christine Vo, Michael E. Carney	2007	28
16	Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer International Journal of Clinical Oncology ·Angeles Alvarez Secord, Laura J. Havrilesky, Michael E. Carney, John T. Soper, Daniel L. Clarke‐Pearson, Gustavo C. Rodriguez, Andrew Berchuck	2007	24
17	Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: A case analysis Gynecologic Oncology ·Galina Lurie, Lynne R. Wilkens, Pamela J. Thompson, Rayna K. Matsuno, Michael E. Carney, Marc T. Goodman	2010	20
18	Quality of Life in Ovarian Cancer Cancer Control ·K.S. Grzankowski, Michael E. Carney	2011	18
19	Catecholamines in urine after death Forensic Science International ·William Tormey, Michael E. Carney, R.J. Fitzgerald	1999	17
20	Effect of delivery route on natural history of cervical dysplasia American Journal of Obstetrics and Gynecology ·Bliss E.K. Kaneshiro, Jared D. Acoba, Jennifer Holzman, K M Wachi, Michael E. Carney	2005	17

About Michael E. Carney

Michael E. Carney is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (14 papers), BRCA gene mutations in cancer (4 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), PARP inhibition in cancer therapy (3 papers), Endometriosis Research and Treatment (3 papers), Cervical Cancer and HPV Research (3 papers) and Cancer Risks and Factors (3 papers). The work is most often cited by research in Reproductive Medicine (928 citations), Obstetrics and Gynecology (549 citations), Oncology (392 citations), Surgery (388 citations) and Cancer Research (122 citations). Michael E. Carney has collaborated with scholars based in United States, Japan and Ireland. Frequent co-authors include Lynda Bergsma, Andrew Berchuck, Johnathan M. Lancaster, Charles L. Wiggins, Alexander Tsodikov, Clyde D. Ford, Craig C. Earle, Robert E. Bristow, Edward L. Trimble and Angela Fahey. Their work appears in journals such as Gynecologic Oncology, American Journal of Obstetrics and Gynecology, Cancer Control, Journal of Clinical Oncology and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact